Top Markets
Coin of the day
Hansa Biopharma AB Hansa Biopharma AB

Hansa Biopharma AB

HNSBF
Classificação em ações #15162
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development... Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Preço da ação
$3.70
Última sincronização: 2026-08-28
Valor de mercado
$369.01M
Variação (1 dia)
0.00%
Variação (1 ano)
35.04%
País
SE
Negociar Hansa Biopharma AB (HNSBF)

Categoria

Histórico de preços das ações de Hansa Biopharma AB (HNSBF)
Preço de fecho mais alto: $3.70 em 2026-08-01

Preço de fecho mais baixo: $4.71 em 2015-03-01
Histórico de preços das ações da Hansa Biopharma AB de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 7.87%
2025 -0.21%
2024 29.03%
2023 -54.16%
2022 -51.64%
2021 -65.44%
2020 200.34%
2019 -69.02%
2018 10.98%
2017 118.54%
2016 302.77%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$61.61 71.22%
US
$51.02 69.30%
SE
$194.29 41.91%
FR
$62.45 0.05%
IT
$113.45 62.73%
US